Inventor · disambiguated record
Heidi N. Leblanc
Also filed as: LEBLANC HEIDI · LEBLANC HEIDI N
22 granted patents·12 pending applications·550 citations·filing 2007–2025
96Inventor score
Top patents by PatentIndex Score
34 records- 0198US11001630B2Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2020·Granted May 11, 2021·10 cites·20 claims
- 0298US10988536B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2020·Granted Apr 27, 2021·10 cites·20 claims
- 0398US10344089B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2017·Granted Jul 9, 2019·25 cites·20 claims
- 0497US11530267B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Dec 20, 2022·2 cites·21 claims
- 0597US11236165B2Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Feb 1, 2022·4 cites·21 claims
- 0697US11236163B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Feb 1, 2022·4 cites·21 claims
- 0797US11236164B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Feb 1, 2022·4 cites·21 claims
- 0897US7960515B2Binding molecules to the human OX40 receptorBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 14, 2011·205 cites·12 claims
- 0996US11512130B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Nov 29, 2022·2 cites·22 claims
- 1096US10988535B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2019·Granted Apr 27, 2021·10 cites·20 claims
- 1196US8236930B2Binding molecules to the human OX40 receptorMIN JING·Filed 2011·Granted Aug 7, 2012·85 cites·5 claims
- 1295US9028824B2Binding molecules to the human OX40 receptorMIN JING·Filed 2012·Granted May 12, 2015·75 cites·22 claims
- 1393US8563694B2Fully human antibodies to BTLAMATARAZA JENNIFER MARIE·Filed 2010·Granted Oct 22, 2013·39 cites·8 claims
- 1490US8680247B2Monoclonal antibodies against glypican-3TERRETT JONATHAN ALEXANDER·Filed 2008·Granted Mar 25, 2014·23 cites·21 claims
- 1590US8481683B2Human antibodies that bind CD22 and uses thereofKING DAVID JOHN·Filed 2007·Granted Jul 9, 2013·31 cites·20 claims
- 1688US9346882B2Fully human antibodies to BTLAMEDAREX LLC·Filed 2013·Granted May 24, 2016·9 cites·22 claims
- 1786US9499632B2Human antibodies that bind CD22 and uses thereofSQUIBB & SONS LLC·Filed 2013·Granted Nov 22, 2016·8 cites·42 claims
- 1886US2023322919A1Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses ThereofSQUIBB & SONS LLC·Filed 2022·Application pending·0 cites
- 1980US2025154254A1Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereofSQUIBB & SONS LLC·Filed 2025·Application pending·0 cites
- 2078US10196452B2Binding molecules to the human OX40 receptorPFIZER·Filed 2017·Granted Feb 5, 2019·1 cites·16 claims
- 2176US2022002428A1Binding molecules to the human ox40 receptorPFIZER·Filed 2021·Application pending·0 cites
- 2274US2020231671A1Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereofSQUIBB & SONS LLC·Filed 2019·Application pending·0 cites
- 2372US8420084B2Fully human antibodies specific to CADM1TERRETT JONATHAN ALEXANDER·Filed 2010·Granted Apr 16, 2013·2 cites·22 claims
- 2472US2011150892A1Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereofMEDAREX INC·Filed 2009·Application pending·0 cites
- 2569US9217033B2Monoclonal antibodies against Glypican-3SQUIBB & SONS LLC·Filed 2014·Granted Dec 22, 2015·1 cites·9 claims
- 2667US2019135932A1Binding molecules to the human ox40 receptorPFIZER·Filed 2019·Application pending·0 cites
- 2759US9840562B2Binding molecules to the human OX40 receptorPFIZER·Filed 2015·Granted Dec 12, 2017·0 cites·24 claims
- 2859US2019119381A1Fully human antibodies to btlaSQUIBB & SONS LLC·Filed 2018·Application pending·0 cites
- 2956US10155813B2Fully human antibodies to BTLASQUIBB & SONS LLC·Filed 2016·Granted Dec 18, 2018·0 cites·4 claims
- 3051US2023069055A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3150US2017058031A1Human antibodies that bind cd22 and uses thereofSQUIBB & SONS LLC·Filed 2016·Application pending·0 cites
- 3249US2013156788A1Fully human antibodies specific to cadm1MEDAREX INC·Filed 2012·Application pending·0 cites
- 3349US2023086603A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3445US2011182904A1Antibodies to bone morphogenic proteins and receptors therefor and methods for their useZIMMERMAN DEBORAH·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heidi N. Leblanc files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →